Noble Equity is a Hedge Fund with a focus on healthcare investments in equities. When the fund was founded in 2007, it mainly focused on under valued medical device, diagnostic, pharmaceutical and service companies. Since 2019, the fund has broadened its focus to include biotechnology companies, primarily with a concentration on neurology, but also in other areas of unmet need.